Dr. Anne Phelan

Chief Scientific Officer

Appointed to role
April 2022, previously in this role at BenevolentAI Ltd since September 2019.

Skills and experience
Anne has over 25 years experience in pharma and biotech. She has led programmes from early discovery through to clinical development across a wide range of therapeutic areas, including CV, pain, A&R, GU and neurodegeneration.

Before joining BenevolentAI, Anne worked for Pfizer for over 15 years, where she was latterly Head of Pharmacology and COO for Pfizer Neusentis. Anne was previously also EVP Head of Research at the biotech Mission Therapeutics. She holds a BSc and PhD in Genetics from the University of Liverpool.